Ticker: GSK CUSIP: 37733W204 Class: SPONSORED ADR
Note: Option positions (PUT/CALL) are excluded.
| Period | Shares | Value ($000) | Average Close | Price Range |
|---|---|---|---|---|
| Q4 2025 | 67,469,409 | $3,308,700 | — | — |
| Q3 2025 | 66,143,500 | $2,854,753 | — | — |
| Q2 2025 | 61,003,544 | $2,342,536 | — | — |
| Q1 2025 | 60,120,517 | $2,329,069 | — | — |
| Q4 2024 | 52,823,032 | $1,786,475 | — | — |
| Q3 2024 | 29,008,928 | $1,185,885 | — | — |
| Q2 2024 | 26,784,583 | $1,031,206 | — | — |
| Q1 2024 | 24,581,222 | $1,053,797 | — | — |
| Q4 2023 | 19,366,131 | $717,709 | — | — |
| Q3 2023 | 18,099,513 | $656,107 | — | — |
| Q2 2023 | 16,808,352 | $599,050 | — | — |
| Q1 2023 | 15,476,432 | $550,651 | — | — |
| Q4 2022 | 14,960,481 | $525,711 | — | — |
| Q3 2022 | 14,067,595 | $414,009 | — | — |